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Introduction
Epstein-Barr virus (EBV) is the causative agent of infectious 
mononucleosis and is associated with several human malig-
nancies (Kieff and Rickinson, 2002). The most abundant of the 
few viral genes (4–11) expressed during EBV latency are the 
noncoding RNAs, EBV-encoded RNA 1 (EBER1) and EBER2, 
which are expressed at  5 × 10
6 per cell (Lerner et al., 1981). 
The EBERs, which are  170 nts in length, are transcribed by 
RNA polymerase III and assembled into nuclear ribonucleo-
protein particles containing the La protein (Lerner et al., 1981). 
EBER1 also binds the ribosomal protein L22 and relocalizes 
a large fraction of the free cellular L22 to the nucleoplasm in 
EBV-positive cell lines (Toczyski et al., 1994).
The physiological function of EBERs has remained 
  elusive. Although not necessary for EBV-mediated immortal-
ization of B cells in vitro, EBERs promote cellular transfor-
mation in various systems (Takada and Nanbo, 2001; Yajima 
et al., 2005) and inhibit apoptosis that is induced by α inter-
feron (Nanbo et al., 2002; Ruf et al., 2005). These activities 
have been attributed to the binding and inhibition of the double-
stranded RNA–dependent protein kinase R (PKR; Sharp 
et al., 1993; Takada and Nanbo, 2001; Nanbo et al., 2002), 
despite multiple studies that have found that EBERs are nu-
cleoplasmic (Howe and Steitz, 1986; Barletta et al., 1993), 
whereas PKR and its well documented effect on translation 
initiation are cytoplasmic (Takizawa et al., 2000). Recent re-
sults (Ruf et al., 2005; Wang et al., 2005) indicate that EBERs 
do not inhibit PKR activity in vivo when cells are challenged 
with various PKR stimuli.
The La protein is an abundant nuclear phosphoprotein 
that facilitates the correct folding and maturation of RNA 
polymerase III transcripts through its specifi  c association with 
the short polyU sequence at their 3′ ends (Wolin and Cedervall, 
2002). The human La protein has also been reported to play a 
role in the translational regulation of some messages (Costa-
Mattioli et al., 2004), including those that harbor unique ter-
minal oligopyrimidine–rich motifs at their 5′ ends. Indeed, an 
unphosphorylated form of La has been detected that is specifi  -
cally bound to terminal oligopyrimidine–  containing mRNAs 
(Intine et al., 2003). Previously, the idea that La actively 
  shuttles between the nucleus and cytoplasm was supported 
only by observations of its localization in drug-treated cells 
  (Bachmann et al., 1989).
We used heterokaryon and other assays to defi  ne the cel-
lular traffi  cking of the EBERs and the La protein. We fi  nd that 
the EBERs are confi  ned to the cell nucleus, whereas the en-
dogenous La protein undergoes nucleocytoplasmic shuttling. 
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T
he Epstein-Barr virus (EBV) noncoding RNAs, EBV-
encoded RNA 1 (EBER1) and EBER2, are the most 
abundant viral transcripts in all types of latently in-
fected human B cells, but their function remains unknown. 
We carried out heterokaryon assays using cells that en-
dogenously produce EBERs to address their trafﬁ  cking, as 
well as that of the La protein, because EBERs are quantita-
tively bound by La in vivo. Both in this assay and in oocyte 
microinjection assays, EBERs are conﬁ  ned to the nucleus, 
suggesting that their contribution to viral latency is purely 
nuclear. EBER1 does not bind exportin 5; therefore, it is 
unlikely to act by interfering with microRNA biogenesis. 
In contrast, La, which is a nuclear phosphoprotein, un-
dergoes nucleocytoplasmic shuttling independent of the 
nuclear export protein Crm1. To ensure that small RNA 
shuttling can be detected in cells that are negative for 
EBER shuttling, we demonstrate the shuttling of U1 small 
nuclear RNA.
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spliceosomal U1 small nuclear RNA (snRNA) does traffi  c to 
the other nucleus in human/mouse heterokaryons that are neg-
ative for EBER shuttling.
Results and discussion
We initially undertook heterokaryon-shuttling experiments 
(Borer et al., 1989) with the well characterized EBV-transformed 
suspension cell line, BJAB-B1. Because these cells did not 
  adhere well to glass slides, we switched to the human HKB5cl8 
cell line, which is a hybrid between human embry  onic kidney 
293S (HEK293S) cells and 2B8 cells, which are an EBV-positive 
Burkitt’s lymphoma B-cell line (Cho et al., 2002; El-Guindy 
et al., 2002). HKB5cl8 cells not only attach to the glass slides 
but are morphologically superior in that the nucleus and cy-
toplasm can be readily distinguished. By RT-PCR analyses 
  (unpublished data), HKB5cl8 cells establish type I latency 
(Kieff and Rickinson, 2002) that is characteristic of Burkitt’s 
  lymphoma cells. We also performed Northern blot analyses 
and found that EBER1 and EBER2 are expressed in HKB5cl8 
(Fig. 1 A, lane 1) at levels only two- to threefold lower than in 
BJAB-B1 cells (Fig. 1 A, lane 3).
To test whether the endogenously expressed EBERs shut-
tle in and out of the nucleus, heterokaryons were formed by 
Figure 1.  EBER1 and EBER2 do not shuttle in HKB5cl8 cells. (A) EBER1 and EBER2 expression in HKB5cl8 cells. A Northern blot of 5 μg total RNA from 
HKB5cl8 (lane 1), BJAB (lane 2), and BJAB-B1 (lane 3) was sequentially probed for EBER1, the U6 loading control, and EBER2. (B) Lack of EBER nucleo-
cytoplasmic shuttling. Heterokaryons were prepared by fusing HKB5cl8 cells transfected with a plasmid producing hnRNP A1-GFP and mouse NIH3T3 cells 
for 6–7 h in the presence of cycloheximide. Heterokaryons were identiﬁ  ed by the shuttling of hnRNP A1-GFP (2 and 5, green) into mouse nuclei, identiﬁ  ed 
by punctate DAPI staining (1 and 4). Human (H) and mouse (M) nuclei of the heterokaryons are labeled. A total of 14 heterokaryons were analyzed. 
  Endogenous EBER1 (3) and EBER2 (6) were detected using DIG-labeled probes (yellow). 
Figure 2.  Detection of 𝗂2 U1 RNA shuttling. (A) Hetero-
karyons were prepared as in Fig.1, except that an α2 
U1–expressing plasmid, rather than an hnRNP A1-GFP–
expressing plasmid, was transfected into HKB5cl8 cells 
and no cycloheximide was added. The two human (H) and 
one mouse (M) nuclei in the heterokaryon are labeled as 
identiﬁ  ed by DAPI (1). The α2 U1 RNA (red) shuttled into 
the mouse nucleus (3), whereas the endogenous EBER1 
(green) did not (2). A total of seven heterokaryons were 
analyzed. (B) Turnover rates of EBER1 compared with U1, 
7SL, and Y1 RNAs. HKB5cl8 (open symbols) and BJAB-B1 
(closed symbols) cells were treated with actinomycin D, 
and the indicated RNAs were detected by Northern blotting. 
Each time point is the mean of three independent experi-
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fusing human HKB5cl8 cells with mouse NIH3T3 cells (Borer 
et al., 1989). The human cells had previously been transfected 
with plasmids expressing the shuttling heterogeneous nuclear 
ribonucleoprotein (hnRNP) A1-GFP protein (Pinol-Roma and 
Dreyfuss, 1991); heterokaryons were identifi  ed by the appear-
ance of hnRNP A1-GFP in both the human and the mouse 
  nuclei (Fig. 1 B, 2 and 5). Mouse nuclei were readily distin-
guished by punctate DAPI staining, which replicates the species-
specifi  c nuclear staining difference previously reported for 
Hoechst dye (Moser et al., 1975).
EBER1 and EBER2 were detected by in situ hybridization 
using DIG-labeled antisense DNA oligonucleotides. These 
probes were complementary to the 3′ half of the EBERs, but 
not to regions including conserved polymerase III promoter 
  elements A and B (which may explain the unique report of 
  cytoplasmic localization of EBERs [Schwemmle et al., 1992]). 
As shown in Fig. 1 B (3–6), EBERs remained in the human 
  nuclei and did not shuttle into the mouse nuclei during the 6-h 
  incubation. HEK293 cells transiently expressing EBERs also 
did not exhibit shuttling (unpublished data); titration of the 
EBER-expressing plasmids showed that in situ hybridization 
signals would have been detected even with RNA levels <10% 
(as observed by Northern blotting; unpublished data).
To ensure that the nucleocytoplasmic shuttling of RNA, as 
well as of protein molecules, could be observed in our assays, 
we examined U1 snRNA. We used a modifi  ed human U1 RNA, 
α2 U1 RNA, in which the fi  rst 20 nts are signifi  cantly different 
from either the human or mouse U1 snRNA (Yuo and Weiner, 
1989). This U1 RNA is functional in vivo (Yuo and Weiner, 
1989) and, therefore, is expected to follow the wild-type matu-
ration pathway, which involves export to the cytoplasm before 
assembly with Sm proteins and reimport into the nucleus (Feeney 
et al., 1989; Mattaj et al., 1993). For heterokaryon assays, we 
transfected an α2 U1 RNA–expressing plasmid into HKB5cl8 
cells and visualized the RNA with probes that hybridize specifi  -
cally to the modifi  ed region. We observed α2 U1 RNA in both 
the human and the mouse nuclei (Fig. 2 A, 3), indicating that α2 
U1 moves out of and back into the nuclei of somatic   human 
cells. Importantly, in the same heterokaryons where U1 shut-
tling was observed, endogenous EBER1 was confi  ned to the 
  human nuclei (Fig. 2 A, 2); the same result was obtained with 
a longer 12-h incubation (not depicted), as opposed to a 6-h 
  incubation. In the RNA-shuttling assays, cycloheximide was 
omitted, ruling out the possibility that the lack of EBER1 shut-
tling is protein synthesis-dependent. EBER2 was also tested, 
but we were unable to fi  nd a hybridization temperature that 
would   allow simultaneous detection of EBER2 and α2 U1 
RNAs (unpublished data).
The absence of EBER signals from mouse nuclei in heter-
okaryons could be attributable to the rapid cytoplasmic degra-
dation of RNA once it is exported from the human nucleus. 
Therefore, we compared the turnover rates of EBER1 and other 
small RNAs; 7SL and Y1 RNAs are both cytoplasmic and 
  transcribed (like EBERs) by RNA polymerase III, whereas U1 
RNA is a nuclear RNA polymerase II product. After the addi-
tion of actinomycin D to HKB5cl8 or BJAB-B1 cells, EBER1 
exhibited an apparent half-life of 25–30 h (Fig. 2 B), which is 
signifi  cantly greater than Y1 (apparent half-life of 7 h; Rutjes 
et al., 1999) and only slightly less than 7SL and U1 (Fury and 
Zieve, 1996). Because shuttling was observed for U1, but not 
for EBER1 (Fig. 2 A), and they are both extremely stable 
RNAs, rapid cytoplasmic degradation cannot explain the lack 
of EBER1 shuttling.
To confi  rm nuclear retention in another system, we per-
formed X. laevis oocyte microinjection assays using in vitro–
transcribed EBER1, U6, and tRNA
Phe. 2.5 h after injection, 
almost all of the positive nuclear export control, tRNA
Phe, was 
detected in the cytoplasmic fraction (Fig. 3 A, lanes 1, 4, and 5). 
In contrast, EBER1 remained in the nucleus, as did the negative 
export control, U6 RNA (Fig. 3 A, lanes 1, 4, and 5). To address 
whether La is responsible for the nuclear retention of EBER1, 
we repeated the microinjection assays using an EBER1 mutant 
lacking its 3′ polyU tail (required for stable La binding); the 
terminal nts were changed from UGUUUUOH to GAACACOH. 
As expected, this EBER1 mutant exhibits eightfold reduced 
binding to La, based on immunoprecipitation using BJAB 
Figure 3.  Lack of oocyte nuclear export and Exp5 binding by EBER1. 
(A) Oocyte microinjections. A mixture of T7-transcribed, α-[
32P]UTP–labeled 
U6, tRNA
Phe, and either wild-type EBER1 or mutant EBER1 lacking its 
3′ polyU terminus (0.5–1 fmol per oocyte) was microinjected into the gemi-
nal vesicles of whole X. laevis oocytes. After either a 0.5-h (wild-type, lanes 
2 and 3; mutant, lanes 7 and 8) or 2.5-h (wild-type, lanes 4 and 5; mutant, 
lanes 9 and 10) incubation at RT, 5–6 oocytes were fractionated. RNAs 
extracted from the nuclear (N), cytoplasmic (C), or total fractions were 
  resolved on a urea polyacrylamide gel and visualized by autoradiography. 
The percentages of RNA in the nucleus are indicated. (B) Electrophoretic 
mobility shift assays performed on binding reactions containing 4.5 fmol 
of labeled VARdm RNA, 1 pmol of recombinant Exp5 (lanes 2–10) and 
RanQ69LGTP (see Materials and methods), and the indicated amounts of 
unlabeled competitor RNA: VARdm (lanes 3 and 4), EBER1 (lanes 5–7), or 
U6 (lanes 8–10). Lane 1 contained no protein. JCB • VOLUME 173 • NUMBER 3 • 2006  322
cell extracts (unpublished data). 2.5 h after injection, mutant 
EBER1 remained in the oocyte nucleus, whereas most tRNA
Phe 
was in the cytoplasm (Fig. 3 A, lanes 6, 9, and 10). Therefore, 
it is unlikely that La is responsible for the nuclear retention 
of EBER1.
Finally, to probe why EBERs are not exported, we 
  performed in vitro exportin 5 (Exp5)–binding assays. Exp5 
mediates nuclear export of premicroRNAs and adenovirus 
noncoding RNA VAI by binding to a terminal stem (Gwizdek 
et al., 2001, 2003; Brownawell and Macara, 2002; Yi et al., 
2003; Lund et al., 2004), which is also proposed to exist in 
EBER1 (Gwizdek et al., 2001). Using an electrophoretic mo-
bility shift assay, we performed competition experiments to 
ask if EBER1 can displace the VARdm RNA (Gwizdek et al., 
2003) from recombinant Exp5. Although unlabeled VARdm 
effi  ciently competed with the Exp5-bound substrate (Fig. 3 B,   
lanes 2–4), neither EBER1 (Fig. 3 B, lanes 5–7) nor the nega-
tive control U6 RNA (Fig. 3 B, lanes 8–10) signifi  cantly dis-
placed the probe, even at 200-fold excess. The same EBER1 
preparation was active in binding its protein ligand L22 (Fok 
et al., 2006). Thus, lack of binding to an export receptor may 
explain why EBER1 is not exported from the nucleus. More-
over, it is unlikely that EBERs function by interfering with 
host cell microRNA biogenesis, which is consistent with ob-
servations (unpublished data) that the level of let-7 microRNA 
is not altered by the presence of EBERs.
Our strategy in investigating the cellular traffi  cking of 
EBERs included testing if its obligatory protein partner La 
  undergoes nucleocytoplasmic shuttling. A typical EBV-infected 
cell harbors  5 × 10
6 copies of each EBER (Lerner et al., 
1981), whereas most human cells express  2 × 10
7 molecules 
of La protein (Wolin and Cedervall, 2002). Thus, even though 
EBERs do not shuttle, the La protein could. To examine La pro-
tein shuttling, HKB5cl8 cells were transfected with plasmids 
expressing either the shuttling hnRNP A1-GFP or the nonshut-
tling hnRNP C1-GFP as controls. After fusion with mouse 
NIH3T3 cells for 4 h, endogenous human La protein was de-
tected using a monoclonal anti-La antibody that does not cross 
Figure 4.  Human La protein undergoes nu-
cleocytoplasmic shuttling in multiple cell lines. 
Heterokaryons were made by fusing HKB5cl8 
(1–6), HeLa (7–9), or HEK293 (10–12) cells, 
which were transfected with a plasmid produc-
ing either the shuttling hnRNP A1-GFP (1–3) or 
the nonshuttling hnRNP C1-GFP (4–12), with 
mouse NIH3T3 cells. After 4 h, human La pro-
tein (red) was detected with a monoclonal anti-
La antibody speciﬁ   c for human La, which is 
demonstrated by the absence of signal in 
the unfused mouse cells labeled m (7, 8, 10, 
and 11). Human (H) and mouse (M) nuclei are 
  labeled as in Fig. 1. More than 20 heterokar-
yons were analyzed.
Figure 5.  Shuttling of the human La protein is 
not blocked by LMB. Heterokaryons were 
made by fusing HEK293 cells transfected with 
plasmids producing Flag-PP32 (1–3) or Flag-
PP32 and hnRNP A1-GFP (4–11) with mouse 
NIH3T3 cells as described in Fig. 4, except 
that no LMB (1–3) or 30 ng/ml LMB (4–11) 
was included during fusion. Detection of the 
human La protein and labeling of the nuclei 
are as described in Fig. 4. La is shown in red 
(2) or in pseudocolor orange (5 and 9). Flag-
PP32 is in green (3) or in pseudocolor deep 
red for infrared (6 and 10). 2 of 11 heterokar-
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react with mouse La protein (unpublished data; Wolin, S., per-
sonal communication), demonstrated by the lack of nuclear 
staining of unfused mouse cells, labeled m in Fig. 4 (panels 7, 
8, 10, and 11) and Fig. 5 (panels 1, 2, 4, and 5).  
Fig. 4 clearly shows that La shuttled from the human nu-
cleus into the mouse nucleus (Fig. 4, panel 2), mimicking the 
shuttling of hnRNP A1-GFP in the same heterokaryon (Fig. 4, 
panel 3). Inclusion of cycloheximide during the fusion period 
ruled out the possibility that newly synthesized human La pro-
tein was imported into mouse nuclei. Although the nonshuttling 
hnRNP C1-GFP remained in the human nucleus (Fig. 4, panel 6), 
the human La protein moved into the mouse nucleus (Fig. 4, 
panel 5). We then confi  rmed that La nucleocytoplasmic shut-
tling is not cell-type specifi  c by repeating the experiments with 
nonvirally infected human cells, HeLa or HEK293. Again, the 
nonshuttling hnRNP C1-GFP remained in the human nuclei and 
the human La protein shuttled into the mouse nucleus in both 
kinds of heterokaryons (Fig. 4, panels 8 and 9 and 11 and 12, 
respectively). We conclude that La, which is predominantly nu-
clear in multiple types of mammalian cells (Wolin and Cedervall, 
2002), has the capacity to exit and return to the nucleus.
Next, we asked whether La protein is exported via the 
Crm1 nuclear export receptor because a human La protein lack-
ing its putative nuclear retention element had been reported to 
accumulate in the cytoplasm, but to be retained in the nucleus in 
the presence of the Crm1 inhibitor leptomycin B (LMB; Intine 
et al., 2002). To ensure that LMB inhibits Crm1 in heterokar-
yons of HEK293 cells and NIH3T3 cells, we included as a con-
trol PP32, which is a known shuttling protein whose nuclear 
export is Crm1-dependent (Brennan et al., 2000). We trans-
fected HEK293 cells with a plasmid-expressing Flag-PP32 and, 
as expected, observed that both La and Flag-PP32 shuttled 
from the human to the mouse nucleus (Fig. 5, panels 2 and 3, 
resp  ectively). In the presence of 30 ng/ml LMB, Flag-PP32, but 
not La, movement was inhibited (Fig. 5, panels 5, 6, 9, and 10). 
In this experiment, hnRNP A1-GFP, which does not require 
Crm1 for nuclear export (Brennan et al., 2000), was coexpressed 
to identify the hybrid cells (Fig. 5, panels 7 and 11). Because 
inhibition of Crm1 blocked the shuttling of Flag-PP32, but not 
of intact La protein, we conclude that the nuclear export of full-
length La is either Crm1 independent or that La is exported by 
more than one pathway. Further studies are needed to resolve 
the pathways and whether the phosphorylation state of La regu-
lates its shuttling activity (Intine et al., 2003).
Because EBERs do not exit the nucleus of either human 
cells (Fig. 1) or Xenopus laevis oocytes (Fig. 3; even in the ab-
sence of a La binding site), it is not the La protein, but rather 
some other feature of their RNA structure, that retains the 
  EBERs in the nucleus of EBV-infected cells. We tested the 
prediction, based on the presence of a terminal stem, that 
  EBERs might bind and interfere with the activity of Exp5 
(Gwizdek et al., 2001), which is limiting in the case of pre-
microRNA   export (Yi et al., 2003). Our fi  ndings suggest that 
EBERs do not function in this way, but instead participate in 
some other exclusively nuclear process that enhances the expres-
sion of several growth factors, including insulin-like growth factor I, 
interleukin-9, and interleukin-10 (Kitagawa et al., 2000; Iwakiri 
et al., 2003; Yang et al., 2004) in EBV-transformed cells. 
Whether these consequences represent an active function of 
the EBER particles or arise through partial sequestration 
of La, ribosomal protein L22, or some other protein partner 
  remains to be determined.
Materials and methods
Cell culture and heterokaryon assays
HKB5cl8, BJAB, and BJAB-B1 cells were grown in RPMI 1640 medium 
  (Invitrogen) containing 10% FBS. HEK293 cells were grown in DME 
(Invitrogen) containing 10% FBS. NIH3T3 cells were grown in DME con-
taining 10% calf serum.
10
5 HKB5cl8 cells were transfected with 2 μg hnRNP A1-GFP, 
hnRNP C1-GFP (both gifts from G. Dreyfuss, University of Pennsylvania 
School of Medicine, Philadelphia, PA), or pα2U1 (Yuo and Weiner, 1989) 
plasmid using 6 μl TransIT reagent (Mirus) for  40 h on coverslips. 
10
5 HeLa cells were transfected with 2 μg hnRNP C1-GFP plasmid using 
6  μl Lipofectamine reagent (Invitrogen) for  40 h on coverslips. 10
5 
HEK293 cells were transfected with 2 μg hnRNP C1-GFP plasmid, 2 μg 
Flag-PP32 plasmid, or 1 μg each of hnRNP A1-GFP and Flag-PP32 plas-
mids using 6 μl TransIT reagent (Invitrogen) for  40 h on coverslips.
For heterokaryon assays, 10
5 mouse NIH3T3 cells were added to 
the transfected human cells described in the previous paragraph and 
  allowed to seed on coverslips for 3 h. 100 μg/ml cycloheximide and 
30 ng/ml LMB, as indicated in the ﬁ  gure legends, were added to the me-
dium to block protein synthesis for 30 min, and the cells were fused using 
50% PEG 3350/PBS for 2 min at RT. Cells were then washed in PBS three 
times and incubated in medium containing 100 μg/ml cycloheximide and 
30 ng/ml LMB, as indicated in the ﬁ  gure legends, for 4–7 h to allow 
shuttling. The lack of signals in mouse nuclei for hnRNP C1-GFP and for 
Flag-PP32 when LMB was added indicates that cycloheximide effectively 
shut down translation. Cells were ﬁ  xed in 4% formaldehyde/PBS and were 
processed for either in situ hybridization or immunoﬂ  uorescence, as de-
scribed in the following sections. Light microscopy and the appearance of 
shuttling proteins in the mouse nuclei were used to identify heterokaryons. 
Fluorescence images were photographed using a digital charge-coupled 
device camera (model C4742-95-12; Hamamatsu) through a microscope 
(Axioplan II; Carl Zeiss MicroImaging, Inc.) with a 40×, 1.3 NA, oil ob-
jective (Plan-Neoﬂ  uar; Carl Zeiss MicroImaging, Inc.). Images were cap-
tured using Openlab imaging software (Improvision) and incorporated into 
ﬁ  gures   using Photoshop CS and Illustrator CS software (both Adobe).
In situ hybridization of EBER and 𝗂2 U1 RNAs
Fixed cells were washed with PBS twice for 5 min, permeabilized with 
0.5% Triton X-100/PBS on ice for 10 min, and washed with PBS once 
and 2× SSC twice at RT. Cells were prehybridized with Phil’s hybridiza-
tion solution at 37°C for 1 h and hybridized with 2 ng/ml EBER1R152 or 
EBER2R134 probe (complementary to EBER1 nts 130–152 or EBER2 nts 
106–134; see Northern blot analysis section for sequences) in Phil’s 
hybridization solution (Forrester et al., 1992) overnight at 37°C. These 
probes were conjugated with DIG label using the 3′-DIG labeling 
kit (Roche) and were detected by incubation with a 1:200 dilution of 
  rhodamine-conjugated anti-DIG antibody (Invitrogen) in PBS at RT for 1 h. 
Cells were washed three times with PBS at RT for 10 min each and once 
with 0.2 μg/ml DAPI/PBS solution at RT for 10 min, and then mounted 
for ﬂ  uorescence microscopy. Alternatively, when EBER1 and α2 U1 were 
simultaneously probed at RT, the following oligonucleotides replaced 
the DIG-labeled probes and anti-DIG antibody: for EBER1, NEB1R148, 
5′-X  C  T  G  G  T  A  C  T  T  G  A  C  C  G  A  A  G  A  C  G  G  C  A  G  A  A  A  -3′; for α2 U1, NHA2U1A, 
5′-X  C  T  G  C  T  T  G  T  G  T  T  A  G  A  T  T  A  T  G  T  G  G  A  T  -3′; and for α2 U1, NHA2U1B, 
5′-X  C  C  C  C  T  G  C  T  T  G  T  G  T  T  A  G  A  T  T  A  T  G  T  G  G  A  T  -3′. X denotes the 5′-amino 
group attached to a six-carbon linker. The 5′-amino group allowed conju-
gation of the Alexa Fluor 488 dye onto NEB1R148 and of the Alexa Fluor 
594 dye onto NHA2U1A and NHA2U1B, using Alexa Fluor Oligonucle-
otide Amine labeling kits (Invitrogen).
Immunoﬂ  uorescence detection of human La and Flag-PP32
Fixed cells on coverslips were washed with PBS twice for 5 min, permeabi-
lized with 0.4% Triton X-100/1% normal goat serum (Invitrogen) in PBS on 
ice for 10 min, and washed with 1% normal goat serum/PBS three times 
at RT for 10 min each. The cells were then incubated with primary anti-
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anti–human La (a gift from M. Bachmann, Technical University Dresden, 
Dresden, Germany) and rabbit polyclonal anti-Flag (Sigma-Aldrich) anti-
bodies were used at 1:100 dilutions. The coverslips were washed three 
times with 1% normal goat serum/PBS at RT for 10 min each, incubated 
with Alexa Fluor 594–conjugated (red) goat anti–mouse (for La) or Alexa 
Fluor 488– (green) or 680–conjugated (infrared) goat anti–rabbit (for Flag-
PP32) antibodies for 1 h, washed three times with PBS at RT for 10 min 
each and once with 0.2 μg/ml DAPI/PBS solution at RT for 10 min, and 
mounted for ﬂ  uorescence microscopy.
Turnover rate measurements
Actively growing HKB5cl8 and BJAB-B1 cells at 4 × 10
5 cells/ml were 
treated with 10 μg/ml actinomycin D. At indicated time points, 2 × 10
5 
cells were removed and pelleted by centrifugation. Total RNAs were ana-
lyzed by Northern blotting.
Northern blot analysis
Total cellular RNA was puriﬁ  ed using Trizol reagent (Life Technologies) and 
5 μg of RNA (Fig. 1), subjected to 7 M urea gel electrophoresis, transferred 
to Zeta-blot (Bio-Rad Laboratories), and cross-linked to the membrane by UV 
irradiation. The immobilized RNA was hybridized with the indicated probe, 
and the signal detected and quantiﬁ  ed with a PhosphorImager (Molecular 
  Dynamics). In Fig.1, EBER levels were normalized to the signal obtained for 
cellular U6 snRNA; the probe was produced from plasmid pT7U6 (Wassarman
and Steitz, 1993) that was linearized with EcoRI and transcribed in the 
presence of α-[
32P]UTP. Other RNA sequences were detected by Northern 
blotting using the following γ-[
32P]–labeled DNA oligonucleotide probes: 
EBER1R152, 5′-C  C  A  G  C  T  G  G  T  A  C  T  T  G  A  C  C  G  A  A  G  A  C  -3′; EBER2R134, 
5′-A  T  T  A  G  A  G  A  A  T  C  C  T  G  A  C  T  T  G  C  A  A  A  T  G  C  T  C  T  -3′; U1R96, 5′-A  A  T  C  G  C  A-
G  G  G  G  T  C  A  G  C  A  C  A  T  C  C  G  G  A  G  -3′; HY1R60, 5′-G  T  T  C  G  A  T  C  T  G  T  A  A  C  T  G  A-
C  T  G  T  G  A-3′  ; and 7SLR99, 5′-G  C  A  T  A  G  C  G  C  A  C  T  A  C  A  G  C  C  C  A  G  A  A  -3′.
Plasmid construction
The wild-type EBER1 coding sequence was cloned into the pUC19 
vector (Fok et al., 2006). Using this plasmid as template, EBER1 3′ 
polyU mutant was generated by PCR ampliﬁ   cation with the primers 
ECORIT7, 5′-C  G  C  G  A  A  T  T  C  T  A  A  T  A  C  G  A  C  T  C  A  C  T  A  T  A  G  -3′ and EBER1PML, 
5′-G    C  C  G  G  A  T  C  C  C  A  C  G  T  G  T  T  C  T  G  C  G  G  A  C  C  A  C  C  A  G  C  T  G  G  T  A  C  T  T  G  A  -3′. 
To generate tRNA
Phe plasmid, oligonucleotides PHE5P, 5′-C  G  C  G  A  A  T  T  C  T-
A  A  T  A  C  G  A  C  T  C  A  C  T  C  T  A  G  G  C  G  A  A  A  T  A  G  C  T  C  A  G  T  T  G  G  G  A  G  A  G  C  G  T  T  A  G-
A  C  T  G  A  A  G  A  T  C  T  A  A  A  G  G  -3′, which contains a T7 promoter, and PHE3P, 
5′-G  C  C  G  G  A  T  C  C  C  A  G  C  T  G  G  T  G  C  C  G  A  A  A  C  C  C  G  G  G  A  T  G  G  A  A  C  C  A  G  G  G  A  C  -
C  T  T  T  A  G  A  T  C  T  T  C  A  G  T  C  T  A  A  C  G  C  T  C  T  C  C  C  -3′ were hybridized and ﬁ  lled in 
with Klenow polymerase. The construct for producing the VARdm substrate 
(Gwizdek et al., 2003) was generated by PCR using pAdEasy (Ameri-
can Type Culture Collection) as a template with primers TopVA, 5′-G  A  C-
C  G  A  A  T  T  C  T  C  G  G  G  A  C  G  C  T  C  T  G  G  C  C  G  G  T  C  A  G  G  -3′, which contains a T7 
promoter, and VA D4M, 5′-C  G  C  G  G  A  T  C  C  A  G  T  A  C  T  A  G  G  A  G  C  A  C  T  C  C  C  C  C-
G  T  T  G  T  C  T  G  A  C  G  T  C  G  C  A  C  A  C  C  T  G  G  G  T  T  A  T  C  A  C  G  G  C  G  G  A  C  G  G  C  C  G  G  A  T-
A  C  G  G  -3′. All DNA fragments were inserted into the pUC19 vector using 
the EcoRI and BamHI restriction sites.
X. laevis oocyte microinjection and RNA isolation
The EBER1 plasmid and pT7U6 were linearized with DraI, the mutant 
EBER1 plasmid with PmlI, and the tRNA
Phe plasmid with PvuII. RNAs were 
in vitro transcribed in the presence of α-[
32P]UTP (GE Healthcare), gel puri-
ﬁ  ed, and injected into the germinal vesicles of whole X. laevis oocytes. 
0.5–1 fmol each of U6 RNA, tRNA
Phe, and EBER1 were injected in a vol-
ume of 9.2 nl with 20 mg/ml blue dextran as a marker. Oocytes were 
  incubated at RT in OR2 buffer (5 mM Hepes, pH 7.8 with KOH, 82.5 mM 
NaCl, 2.5 mM KCl, 1 mM Na2HPO4, 1 mM MgCl2, and 1 mM CaCl2) for 
0.5 or 2.5 h and manually dissected in cold isolation buffer (80 mM KCl, 
17 mM NaCl, 6 mM Na2HPO4, 3.5 mM KH2PO4, and 10 mM MgCl2). 
Five to six oocytes were fractionated into nucleus and cytoplasm (Huang 
and Steitz, 2001) and pooled for each time point. Proteinase K digestion 
and phenol/choloform extraction were performed, and 0.5 oocyte equiva-
lents were run on an 8% urea polyacrylamide gel.
Immunoprecipitation of wild-type and mutant EBER1
The La-speciﬁ  c antiserum used was ON, which was provided by J.   Hardin 
(Yale University, New Haven, CT). Whole-cell sonicates (16 μl) from 2 × 10
5 
BJAB cells (Lerner et al., 1981) were incubated with 40 fmol ( 2 × 10
5 
cpm) in vitro α-[
32P]UTP–labeled wild-type or mutant EBER1 and 2 μg 
Escherichia coli tRNA as a nonspeciﬁ  c competitor in 20 μl for 30 min 
at RT. The reactions were immunoprecipitated with either anti-La or 
anti-L22 (Toczyski et al., 1994) attached to protein A–Sepharose beads 
(GE Healthcare), or beads alone at 4°C for 1–2 h. The beads were then 
washed ﬁ  ve times with NET-2 (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 
and 0.05% NP-40) at 4°C. RNA was extracted with phenol/chloroform/
isoamyl alcohol (25:25:1), ethanol-precipitated, and electrophoresed in 
an 8% urea polyacrylamide gel. Equal amounts of wild-type and mutant 
EBER1 were immunoprecipitated in control reactions with anti-L22, sug-
gesting proper folding of the EBER1 mutant.
Recombinant proteins
Expression and puriﬁ  cation of Exp5 was performed as previously de-
scribed (Brownawell and Macara, 2002), except that the puriﬁ  ed pro-
tein was dialyzed against buffer A (20 mM TrisHCl, pH 7.5, 100 mM 
KCl, 2 mM MgCl2, 2 mM DTT, and 10% glycerol). RanQ69LGTP was 
prepared as previously described (plasmid provided by I. Macara, 
  University of Virginia, Charlottesville, VA; Brownawell and Macara, 
2002; Rebane et al., 2004).
Electrophoretic mobility shift assays
The VARdm substrate (Gwizdek et al., 2003) was generated from the 
VARdm plasmid linearized with ScaI by in vitro transcription in the pres-
ence of α-[
32P]UTP. Binding reactions (10 μl) containing 4.5 fmol VARdm 
RNA, 0.1 μM Exp5, 0.5 μM RanQ69LGTP, and the indicated amounts 
of competitor RNAs were incubated for 40 min at 30°C in RNA-binding 
buffer containing 20 mM TrisHCl, pH 7.5, 100 mM KCl, 2 mM MgCl2, 
2 mM DTT, 10% glycerol, and 2 pmol of the T7 terminator DNA olig-
onucleotide 5′-G  C  T  A  G  T  T  A  T  T  G  C  T  C  A  G  C  G  G  -3′ to reduce nonspeciﬁ   c 
binding. Before loading, 1 μl of a 0.6 mg/ml heparin and 0.2 mg/ml 
Bromophenol blue mixture was added to each sample. The samples were 
loaded on a preelectrophoresed (30 min) 6% native gel in 0.5× TBE 
  buffer (45 mM Tris borate and 1 mM EDTA). Electrophoresis was per-
formed at 12 V cm
–1 for 1 h at RT.
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